🏥 Health
1d ago
Up to 40% of Diabetes Patients Achieved Normal HbA1c With Retatrutide
Source ↗
👁 0
💬 0
(MedPage Today) -- NEW ORLEANS -- Monotherapy with once-weekly retatrutide, an investigational triple hormone receptor agonist, improved glycemic control and body weight in adults with type 2 diabetes, the phase III TRANSCEND-T2D-1 trial showed...
Comments (0)